Dr. Anthony Atala

• 
  reflectionsofaparalytic.com/?p=250#respond - [Cached Version]
  Last Visited: 4/17/2007  

  Anthony Atala, director of the Institute for Regenerative Medicine at Wake Forest University School of Medicine, reported that stem cells in the amniotic fluid that fills the sac surrounding the fetus may be just as versatile as embryonic stem cells.
  ...
  As Atala told PBS's Online NewsHour, "We have been able to drive the cell to what we call all three germ layers, which basically means all three major classes of tissues available in the body, from which all cells come from."
  ...
  Amniotic and placenta stem cells are the same, as Atala himself noted.

• 
  ads.cednc.org/conferences/venture/2007/presenters/index - [Cached Version]
  Published on: 4/20/2007    Last Visited: 8/10/2007  

  Dr. Tony Atala, director of Wake Forest University's Institute for Regenerative Medicine, is Tengion's scientific founder.

• 
  triad.bizjournals.com/triad/stories/2009/02/09/daily61. - [Cached Version]
  Published on: 2/12/2009    Last Visited: 2/12/2009  

  "This partnership offers the potential to speed scientific development and make advances in regenerative medicine available to patients around the world," said Dr. Anthony Atala, director of Wake Forest's institute.

• 
  www.spacedaily.com/reports/Stem_Cell_Sales_To_Top_35_Mi - [Cached Version]
  Published on: 1/16/2008    Last Visited: 1/16/2008  

  Anthony Atala, head of Wake Forest's regenerative medicine institute, and colleagues recently announced they had found embryonic-like stem cells in amniotic fluid -- the liquid surrounding fetuses in the womb -- using a procedure that does not require destroying embryos.

• 
  archive.intouchsol.net/articles/detail/detail1.asp?id=2 - [Cached Version]
  Published on: 7/3/2007    Last Visited: 7/3/2007  

  "You can't say one cell type is better than another," said Dr. Anthony Atala, director of Wake Forest's Institute for Regenerative Medicine, who is leading one stem cell comparison study.
  ...
  This year, for example, Atala published a paper detailing a novel method of obtaining stem cells from amniotic fluid.Critics of embryonic research cheered the method as a replacement for embryonic stem cells, but Atala says it is not that simple.
  
  So far, Atala said, it seems that his cells may be more stable than embryonic cells and less prone to produce tumors in patients--but they also appear to be less versatile.
  ...
  Yet Atala is more cautious in describing his work.
  
  Though it might seem good that Atala's cells do not become genetically unstable and form tumors, that could also be a drawback of sorts, he said.
  
  Part of the value of embryonic stem cells is the genetic flexibility that lets them develop into different cell types.Left unchecked, the cells can form a kind of benign tumor called a teratoma, which contains many kinds of tissue.In fact, the ability to form teratomas is part of the scientific definition of embryonic stem cells.
  
  Because amniotic-derived stem cells do not form tumors, "it stands to reason that they will not be as nimble" as embryonic stem cells, Atala said.
  
  The need to understand such subtle differences is a major reason for the collaboration between Atala and Robert Lanza, vice president of research and development at California-based Advanced Cell Technology.

• 
  www.baptistpress.org/storydownload.asp?ID=23012 - [Cached Version]
  Published on: 4/14/2006    Last Visited: 4/14/2006  

  The bladders have shown long-term success in children and teenagers, according to a report from Anthony Atala, director of the Institute for Regenerative Medicine at Wake Forest University School of Medicine in Winston-Salem, N.C.

• 
  www.futurefeeder.com/2005/06/stem-cells-from-human-skin - [Cached Version]
  Published on: 1/1/2005    Last Visited: 9/28/2009  

  “Because these cells are taken from a patient’s own skin, there would not be problems with organ or tissue rejection. . . The ability to engineer tissues from a patient’s own cells may overcome two major problems in transplantation medicine: immune rejection and tissue shortage,� said Anthony Atala, M.D., director of the Wake Forest Institute for Regenerative Medicine and senior researcher on the project.

• 
  www.spectrum.ieee.org/htmlCache/2002-06-03T212736Z_01_N - [Cached Version]
  Published on: 6/7/2002    Last Visited: 6/7/2002  

  "We believe we have shown that this is not the case," said Dr. Anthony Atala of Harvard University and Children's Hospital, who worked on the study.
  
  The team removed some of the tissue from their tiny cloned embryos.They seeded kidney tissue onto artificial structures that they hoped would grow into kidneys when transplanted back into the steer they were cloned from.
  
  It worked even better than expected.
  
  ...
  No one has cloned a human embryo, but Atala said the experiment may be even easier to do in people.The promise of cloning lies in the embryonic stem cells, cells that have the power to become any kind tissue in the body at all.
  
  Experiments on embryos left over from test-tube fertility attempts have shown these stem cells are readily found in a human embryo that is smaller than the head of a pin.
  
  If cloning can be shown to work in humans, and if it remains legal, then theoretically a plug of skin could be taken from a patient and used to grow a new heart, brain cells or other tissue for transplant.

• 
  www.spacedaily.com/reports/An_End_To_The_Stem_Cell_Deba - [Cached Version]
  Published on: 1/16/2008    Last Visited: 1/16/2008  

  "Our hope is that these cells will provide a valuable resource for tissue repair and for engineered organs as well," said Anthony Atala, director of Wake Forest's Institute for Regenerative Medicine and leader of the team that also included researchers at Harvard Medical School.
  
  Atala explained that, although it was common knowledge that the amniotic fluid contained progenitor cells from the developing embryo, no one knew whether or not they were true stem cells that could differentiate into all the tissues of the body.
  
  And he said it took him and his colleagues seven years of work to find out.
  ...
  Atala told UPI the stem cells are still in the early stages of development and will not be used in human beings any time soon, but added he was enthusiastic about their potential since several strains have been used to successfully repair diseased tissue in mice.
  
  He also noted that, since he and his colleagues wrote up their work for journal publication, nerve cells developed from AFS cells have started producing dopamine -- which he said is a fairly high functional end product for this type of tissue -- and liver cells have started secreting urea.
  
  The team has postulated that an AFS cell bank with 100,000 specimens could supply 99 percent of the U.S. population with a perfect genetic match for transplantation.They wrote that they thought there would be no problem obtaining that many specimens since there are more than 4 million live births each year in the United States alone.
  
  When asked about a skeptical comment from Clive Svendsen, a stem cell researcher at the University of Wisconsin in Madison who read the team's paper and thought AFS neural stem cells did not compare well to neural stem cells that were derived from the brain, Atala said he had no quarrel with Svendsen's analysis.
  
  "He's right so far," Atala told UPI.

• 
  www.fumento.com/weblog/atom.xml - [Cached Version]
  Published on: 4/22/2006    Last Visited: 3/7/2007  

  Anthony Atala's work reported in January using amniotic stem cells is only the latest.
  ...
  As I observe in the February 8 Daily Standard, Anthony Atala, director of the Institute for Regenerative Medicine at Wake Forest University School of Medicine, reported that stem cells in the amniotic fluid that fills the sac surrounding the fetus may be just as versatile as embryonic stem cells.
  ...
  In a later post, our greedy friend tried to defend "Andy X." Andy X's comment (aside from implicating my sexuality) was that I criticized Newsweek for saying, "Many scientists are quick to emphasize that comprehensive human trials [on amniotic/placenta cells such as those discussed in a new paper by Anthony Atala] are still many years away."
  ...
  We therefore have Joe Katzman saying that Atala (and by derivation, Fumento) is lying about Atala's paper.Personally - and call me crazy - I'm going to go ahead and side with Atala.

Page:  1 2 3 4 5